QOF · 2026/27

QOF — Quality & Outcomes Framework 2026/27

Last update

15 August 2026

Data source

Clinical system

Refresh

Weekly · live

Next refresh

Auto · weekly

Indicator type

Date window

PCN & Practice

View as at

KPIs on target

1/36

35 below · 4 monitoring

Performance

48.0%

34 payment KPIs

Highest performing

VI004

85.2% · target 50–60% · +25.2%

471 / 553

Lowest performing

DM006

7.6% · target 57–97% · -89.4%

209 / 2,768

Most improved

—

Needs 2+ uploads

On target (1)Near target (6)Below target (27)No data (6)Mon= Monitoring only — no payment threshold

Indicator⇅	Target⇅	Target activity⇅	Performance %⇅	Activity⇅	Population⇅	Shortfall⇅	Status
Respiratory
AST007Asthma with review in last 12 months▸	45–70%	9,193	39%	5,123	13,132	4,070	Below
AST012Asthma with objective tests recorded▸	45–80%	703	67.4%	592	878	111	Below
COPD010COPD with review including exacerbations, breathlessness▸	50–90%	3,222	32.9%	1,178	3,580	2,044	Below
Cardiovascular
AF006Patients with AF and CHA2DS2-VASc score▸	40–95%	685	61.9%	446	721	239	Below
AF008Patients with AF and a CHA2DS2-VASc score>=2 on DOAC /Vit K antagonist▸	70–95%	1,550	5.8%	95	1,631	1,455	Below
BP002Patients aged 45 or over and blood pressure recorded▸	50–90%	86,057	87.7%	83,896	95,618	2,161	Near
CHD005CHD taking anti-platelet or anti-coagulant▸	56–96%	5,902	87.7%	5,388	6,147	514	Near
CHOL003Patients with CHD / PAD / TIA / CKD on statin/lipid-lowering therapy▸	70–95%	7,595	6.5%	521	7,994	7,074	Below
CHOL004Patients with LDL cholesterol <=2.0 or non-HDL <=2.6▸	20–50%	4,298	30.4%	2,610	8,595	1,688	Below
HF007Heart failure with review of functional capacity, medication▸	50–90%	1,586	14.9%	263	1,762	1,323	Below
HF008Heart failure diagnosis from 1 April 2023 with ECHO or specialist assess▸	50–90%	680	83.2%	628	755	52	Near
HF009HF patients on ACE-I/ARB/ARNI, beta-blocker, MRA and SGLT2 inhibitor FYMon▸	Monitoring	—	0.4%	1	251	—	Monitoring
HYP008Hypertension aged 79 or under BP 140/90 mmHg or less▸	40–85%	20,265	45.6%	11,989	26,318	8,276	Below
HYP009Hypertension aged 80 or over BP 150/90 mmHg or less▸	40–85%	1,724	47.5%	1,023	2,154	701	Below
STIA007Non-haemorrhagic stroke or TIA taking anti-platelet or anti-coagulant▸	57–97%	1,729	85.6%	1,525	1,782	204	Near
Dementia
DEM004Dementia and review done▸	35–70%	760	20.7%	225	1,085	535	Below
Mental Health
MH002Mental health and care plan documented▸	40–90%	3,997	24.2%	1,075	4,441	2,922	Below
MH003Mental health problems and BP recorded in the preceding 12 months▸	50–90%	4,091	47.3%	2,151	4,545	1,940	Below
MH006Mental health problems and BMI recorded in the preceding 12 months▸	50–90%	4,086	43.2%	1,961	4,540	2,125	Below
MH007Mental health problems and alcohol recorded in last 12 months▸	50–90%	4,087	42%	1,907	4,541	2,180	Below
MH011Mental health problems and lipids recorded in last 12 months▸	50–90%	4,080	45.1%	2,044	4,533	2,036	Below
MH012Mental health problems and glucose/Hba1c recorded in last 12 months▸	NIS	—	—	1,207	—	—	No data
Diabetes
DM006Diabetes and proteinuria or micro-albuminuria taking ACE-I or ARB▸	57–97%	2,685	7.6%	209	2,768	2,476	Below
DM014Newly diagnosed with diabetes referred to structured education programme▸	40–90%	620	50.6%	348	688	272	Below
DM020Diabetes no moderate/severe frailty IFCC-HbA1c is 58 mmol/mol or less▸	35–75%	16,188	31.6%	6,812	21,583	9,376	Below
DM021Diabetes with frailty IFCC-HbA1c is 75 mmol/mol or less▸	NIS	—	—	1,224	—	—	No data
DM034Diabetes aged >=40 no CVD/frailty on statin or lipid-lowering therapy▸	50–90%	11,157	7.1%	881	12,396	10,276	Below
DM035Diabetes with CVD (not haemorrhagic) on statin or lipid-lowering therapy▸	50–90%	5,635	8.6%	540	6,261	5,095	Below
DM036Diabetes no moderate/severe frailty BP 140/90 mmHg or less▸	38–90%	20,322	53%	11,100	20,950	9,222	Below
DM037Diabetes with care processes performed in last 12 months FYMon▸	Monitoring	—	34.4%	8,323	24,198	—	Monitoring
Vaccination & Immunisation
VI001Three or more DTaP vaccine doses before 8 months▸	89–96%	3,739	57.2%	2,226	3,894	1,513	Below
VI002One or more MMR doses aged 12-18 months▸	86–96%	3,831	57.5%	2,296	3,990	1,535	Below
VI003Aged 1-5 years with DTaP/IPV booster and at least 2 doses of MMR▸	81–96%	3,425	69.7%	2,486	3,567	939	Below
VI004Aged 80 with shingles vaccine received between 70-79 years▸	50–60%	332	85.2%	471	553	Met	Met
Cervical Screening
CS005Aged 25-49 adequate smear last 3 years and 6 months▸	45–80%	65,879	53%	43,628	82,348	22,251	Below
CS006Aged 50-64 adequate smear last 5 years and 6 months▸	45–80%	14,120	76.3%	13,470	17,649	650	Near
Smoking
SMOK002Chronic disease and smoking status recorded▸	50–90%	53,244	83.4%	49,366	59,160	3,878	Near
SMOK004Current smokers with an offer of support given▸	40–90%	42,087	72.8%	34,042	46,763	8,045	Below
Obesity
OB004Patients age >=18 with obesity referred to weight management FYMon▸	Monitoring	—	7.7%	1,119	14,559	—	Monitoring
OB005Patients NICE TA1026 cohort,shared decision,meds,behavioural referral FYMon▸	Monitoring	—	1.2%	2	167	—	Monitoring

Data as of 15 August 2026 · Clinical system · Refreshed weekly